Marchetti, Monia
 Distribuzione geografica
Continente #
EU - Europa 178
NA - Nord America 116
AS - Asia 56
Continente sconosciuto - Info sul continente non disponibili 2
Totale 352
Nazione #
US - Stati Uniti d'America 114
IE - Irlanda 87
SE - Svezia 36
HK - Hong Kong 30
DE - Germania 19
IT - Italia 16
SG - Singapore 13
IN - India 11
BE - Belgio 7
CZ - Repubblica Ceca 7
FI - Finlandia 3
CA - Canada 2
EU - Europa 2
TW - Taiwan 2
ES - Italia 1
GB - Regno Unito 1
UA - Ucraina 1
Totale 352
Città #
Dublin 85
Hong Kong 30
Chandler 20
Bremen 10
Lawrence 9
Princeton 9
Boardman 8
Singapore 8
Brno 7
Delhi 6
Aalst 4
Ashburn 3
Asti 3
Brussels 3
Helsinki 3
Novara 3
Chicago 2
Jacksonville 2
Kolkata 2
Mülheim 2
New Delhi 2
Piemonte 2
San Mateo 2
Turin 2
Wilmington 2
Alba 1
Andover 1
Arona 1
Bonnybridge 1
Cagliari 1
Córdoba 1
Fairfield 1
Houston 1
Los Angeles 1
Milan 1
Montreal 1
Munich 1
Sacramento 1
Toronto 1
Woodbridge 1
Totale 244
Nome #
FRONTLINE THERAPY FOR NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA: A CRITICAL APPRAISAL OF PUBLISHED NETWORK META-ANALYSES 62
Mental health in migrants contacting the mental health operational unit of the National Institute for Health, Migration and Poverty (NIHMP): preliminary data 44
PRIMARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN PATIENTS AFFECTED BY HAEMATOLOGICAL MALIGNANCIES (LYMPHOMA, MULTIPLE MYELOMA, ACUTE LEUKAEMIA): GUIDELINES FORM THE ITALIAN SOCIETY OF HAEMATOLOGY 38
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 37
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 34
RISK ASSESSMENT MODELS (RAM) OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH BLOOD CANCERS: A SYSTEMATIC REVIEW 29
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group 26
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study 24
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 24
Comparative clinical value of pharmacologic therapies for B-cell chronic lymphocytic leukemia: an umbrella analysis 23
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 22
Totale 363
Categoria #
all - tutte 2.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 1 1 1 0 1 0 1 0
2021/202245 3 0 1 0 1 1 0 5 1 7 4 22
2022/2023196 11 10 15 3 13 17 7 17 90 0 9 4
2023/2024113 7 6 9 0 9 0 29 2 2 5 19 25
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 363